An international team used multi-omics to connect the gut microbiome to atherosclerosis biology by identifying a pathway involving SYNPO2/VNN1 and proposing a microbiota-based vaccine angle. The study reports a molecular pathway that links microbial inputs with host processes tied to plaque development, aiming to translate mechanistic targets into immunomodulatory strategies for cardiovascular risk.